Vishal Gupta is a Cardiology physician affiliated with Borgess Medical Center. OpenAlex indexes 10 publications with 425 citations (h-index 3); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1717 Shaffer St
Suite 232
Kalamazoo, MI 490481647
Telephone
269-226-5050Registry record last updated 11 Jun 2015.
Clinical trials
- Evaluation of Asymptomatic Coronary Atherosclerotic Disease Among People of Kalamazoo, MI
Sponsor: Borgess Research Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
51 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year202515 payments$10,855openpaymentsdata.cms.gov ↗
- E.R. Squibb & Sons, L.L.C.Program year202512 payments
- CARDIVA MEDICAL, INC.Program year202510 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
75.5%Statin16.5%Atorvastatin Calcium49%Rosuvastatin Calcium48%Pravastatin Sodium3%Part D<11 patientsBeta blocker15.2%Metoprolol Succinate58%Metoprolol Tartrate24%Carvedilol18%Part D≥74 patients+ 16 more classes in this area
Blood & clotting
20.4%P2Y12 inhibitor9.2%Clopidogrel88%Prasugrel Hcl12%Part D<11 patientsFactor Xa inhibitor9%Eliquis64%Xarelto36%Part D≥40 patients+ 1 more class in this area
Metabolism & gastrointestinal
4%SGLT2 inhibitor3.1%Jardiance100%Part D≥27 patientsPotassium supplement0.9%Potassium Chloride100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Reno-Protective Effects of SGLT2 Inhibitors in Patients With Diabetes Undergoing Percutaneous Coronary Intervention: Insights From the BMC2 Registry
Circulation Cardiovascular Interventions
2026 - Comparative outcomes of percutaneous coronary intervention in ST-elevation myocardial infarction: an analysis by infarct-related coronary artery
Baylor University Medical Center Proceedings
2025 - CRT-300.17 Prevalence of Iliac Dissections During Coronary Angiograms From Femoral Approach: Single-Center Experience
JACC: Cardiovascular Interventions
2022 - USE OF DYEVERT PLUS TO REDUCE CONTRAST EXPOSURE IN HIGH-RISK PATIENTS UNDERGOING CORONARY ANGIOGRAPHY
Journal of the American College of Cardiology
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”